Table 1 Mean baseline characteristics of TAVI and AVR patients aged ≥ 75 years
From: In-hospital resource utilization in surgical and transcatheter aortic valve replacement
AVR | TAVI | AVR vs. TAVI | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
All | TF-TAVI | TA-TAVI | TF vs. TA-TAVI | |||||||
27 | 83 | 60 | 23 | p-value | p-value | |||||
Demographics | ||||||||||
Age | 78.74 | ±3.43 | 82.9 | ±4.48 | 82.95 | ±4.67 | 82.78 | ±4.03 | p <0.01 | 0.963 |
Female | 44 % | 67 % | 68 % | 65 % | 0.029 | 0.798 | ||||
Medical History | ||||||||||
LVEF (%) | 50.37 | ±12.8 | 50.52 | ±9.62 | 51.2 | ±9.25 | 48.47 | ±10.68 | 0.785 | 0.257 |
AVA | 0.81 | ±0.17 | 0.68 | ±0.16 | 0.68 | ±0.17 | 0.65 | ±0.14 | p <0.01 | 0.9796 |
Renal diseasea | 56 % | 64 % | 57 % | 83 % | 0.183 | 0.043 | ||||
CAD | 37 % | 54 % | 55 % | 52 % | 0.183 | 1.000 | ||||
Previous MI | 11 % | 22 % | 17 % | 35 % | 0.272 | 0.084 | ||||
Previous PCI | 19 % | 24 % | 23 % | 26 % | 0.609 | 0.781 | ||||
Previous Stroke | 4 % | 7 % | 5 % | 13 % | 1.000 | 0.340 | ||||
Previous CABG | 4 % | 12 % | 8 % | 22 % | 0.288 | 0.131 | ||||
AF | 33 % | 41 % | 33 % | 61 % | 0.507 | 0.027 | ||||
Hypertension | 93 % | 83 % | 85 % | 78 % | 0.348 | 0.518 | ||||
DM | 33 % | 27 % | 25 % | 30 % | 0.623 | 0.782 | ||||
Liver disease | 4 % | 6 % | 5 % | 9 % | 1.000 | 0.614 | ||||
COPD | 11 % | 16 % | 13 % | 22 % | 0.757 | 0.336 | ||||
PVD | 4 % | 20 % | 17 % | 30 % | 0.068 | 0.224 | ||||
Quality of lifeb | 0.84 | ±0.21 | 0.79 | ±0.21 | 0.8 | ±0.22 | 0.76 | ±0.17 | 0.062 | 0.134 |
proBNP (pg/ml) | 1474 | ±1708 | 4098 | ±6576 | 3820 | ±6111 | 4805 | ±7749 | 0.654 | 0.760 |
Risk Scores | ||||||||||
EuroScore I | 10.44 | ±6.21 | 20.66 | ±13.05 | 18.53 | ±10.16 | 25.87 | ±17.49 | p <0.01 | 0.065 |
EuroScore II | 3.54 | ±3.15 | 6.77 | ±5.59 | 5.83 | ±4.09 | 9.04 | ±7.84 | p <0.01 | 0.094 |
STS-Score | 3.48 | ±1.57 | 5.7 | ±3.36 | 5.48 | ±2.88 | 6.21 | ±4.35 | p <0.01 | 0.505 |